A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda
- PMID: 39136465
- PMCID: PMC11382623
- DOI: 10.1128/aac.01576-23
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda
Abstract
The emergence of drug-resistant Plasmodium falciparum parasites in sub-Saharan Africa will substantially challenge malaria control. Here, we evaluated the frequency of common drug resistance markers among adolescents from Northern Uganda with asymptomatic infections. We used an established amplicon deep sequencing strategy to screen dried blood spot samples collected from 2016 to 2017 during a reported malaria epidemic within the districts of Kitgum and Pader in Northern Uganda. We screened single-nucleotide polymorphisms within: kelch13 (Pfk13), dihydropteroate synthase (Pfdhps), multidrug resistance-1 (Pfmdr1), dihydrofolate reductase (Pfdhfr), and apical membrane antigen (Pfama1) genes. Within the study population, the median age was 15 years (14.3-15.0, 95% CI), and 54.9% (78/142) were Plasmodium positive by 18S rRNA qPCR, which were subsequently targeted for sequencing analysis. We observed a high frequency of resistance markers particularly for sulfadoxine-pyrimethamine (SP), with no wild-type-only parasites observed for Pfdhfr (N51I, C59R, and S108N) and Pfdhps (A437G and K540E) mutations. Within Pfmdr1, mixed infections were common for NF/NY (98.5%). While for artemisinin resistance, in kelch13, there was a high frequency of C469Y (34%). Using the pattern for Pfama1, we found a high level of polygenomic infections with all individuals presenting with complexity of infection greater than 2 with a median of 6.9. The high frequency of the quintuple SP drug-resistant parasites and the C469Y artemisinin resistance-associated mutation in asymptomatic individuals suggests an earlier high prevalence than previously reported from symptomatic malaria surveillance studies (in 2016/2017). Our data demonstrate the urgency for routine genomic surveillance programs throughout Africa and the value of deep sequencing.
Keywords: Plasmodium falciparum; amplicon sequencing; artemisinin resistance; molecular surveillance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Prevalence of antimalaria drug resistance-conferring mutations associated with sulphadoxine-pyrimethamineine-resistant Plasmodium falciparum in East Africa: a systematic review and meta-analysis.Ann Clin Microbiol Antimicrob. 2025 Apr 16;24(1):25. doi: 10.1186/s12941-025-00795-7. Ann Clin Microbiol Antimicrob. 2025. PMID: 40241183 Free PMC article.
-
Screening for antifolate and artemisinin resistance in Plasmodium falciparum dried-blood spots from three hospitals of Eritrea.F1000Res. 2024 Jun 12;10:628. doi: 10.12688/f1000research.54195.4. eCollection 2021. F1000Res. 2024. PMID: 38840941 Free PMC article.
-
Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities in 2021 and 2022.Sci Rep. 2025 Aug 11;15(1):29335. doi: 10.1038/s41598-025-02166-w. Sci Rep. 2025. PMID: 40790052 Free PMC article.
-
Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0165923. doi: 10.1128/aac.01659-23. Epub 2024 Jul 19. Antimicrob Agents Chemother. 2024. PMID: 39028193 Free PMC article.
-
Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Malar J. 2010 Aug 30;9:247. doi: 10.1186/1475-2875-9-247. Malar J. 2010. PMID: 20799995 Free PMC article.
Cited by
-
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.BMC Infect Dis. 2025 Jan 16;25(1):73. doi: 10.1186/s12879-025-10462-z. BMC Infect Dis. 2025. PMID: 39819451 Free PMC article.
-
Plasmodium falciparum Kelch-13 artemisinin partial resistance markers in Fort Portal, Western Uganda, 2024.Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0175524. doi: 10.1128/aac.01755-24. Epub 2025 Apr 23. Antimicrob Agents Chemother. 2025. PMID: 40265952 Free PMC article.
-
Artemisinin-resistant malaria.Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15. Clin Microbiol Rev. 2024. PMID: 39404268 Review.
References
-
- WHO . 2023. World malaria report 2023. World Health Organization
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials